Difference between revisions of "Research:Coronavirus vaccine"
(complying with new guidelines) |
(formatting) |
||
| Line 35: | Line 35: | ||
* COVID-19 vaccine: >1000 | * COVID-19 vaccine: >1000 | ||
* SARS-CoV-2 vaccine: >1000 | * SARS-CoV-2 vaccine: >1000 | ||
Latest revision as of 19:09, 7 March 2022
Research
Variants and synonyms
- COVID-19 vaccine
- SARS-CoV-2 vaccine
Definition/description
Efforts to design a coronavirus vaccine have focused on a variety of approaches including development of inactivated virus, live-attenuated virus, and a variety of subunit vaccines.
Source: https://www.mdpi.com/1999-4915/6/7/2531
All coronavirus vaccine candidates are directed against the Spike protein (S protein), the most immunological component of coronaviruses.
Source: https://www.mdpi.com/2414-6366/4/1/31
Examples
The re-emergence of lethal coronaviruses calls for international collaboration to produce coronavirus vaccines, which are still lacking to date.
Source: https://www.sciencedirect.com/science/article/pii/S1879625716301481?via%3Dihub
They summarize the challenges of developing a successful, protective coronavirus vaccine, especially for SARS-CoV.
Source: https://www.futuremedicine.com/doi/10.2217/17460794.3.2.119
Collocations
- novel coronavirus vaccine
- develop coronavirus vaccine
- efficient coronavirus vaccine
- efficacious coronavirus vaccine
- live / killed coronavirus vaccine
- coronavirus vaccine development
- coronavirus vaccine candidate
Keyness
- coronavirus vaccine: >1000
- COVID-19 vaccine: >1000
- SARS-CoV-2 vaccine: >1000